{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:01:21Z","timestamp":1773698481342,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Almirall"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.rmed.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T01:45:35Z","timestamp":1439430335000},"page":"1305-1311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside"],"prefix":"10.1016","volume":"109","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josuel","family":"Ora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermanno","family":"Puxeddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2015.08.005_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1586\/17512433.2015.977256","article-title":"Umeclidinium bromide\u00a0+\u00a0vilanterol for the treatment of chronic obstructive pulmonary disease","volume":"8","author":"Matera","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2015.08.005_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000368986","article-title":"Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol\/glycopyrronium","volume":"94","author":"Pelaia","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.rmed.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pupt.2010.03.003","article-title":"The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD","volume":"23","author":"Cazzola","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2014.10.025","article-title":"Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi","volume":"745","author":"Cazzola","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"109","key":"10.1016\/j.rmed.2015.08.005_bib5","first-page":"295","article-title":"Tidal stretches do not modulate responsiveness of intact airways in\u00a0vitro","volume":"2010","author":"LaPrad","year":"1985","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.rmed.2015.08.005_bib6","first-page":"H655","article-title":"Contractile properties of isolated vascular smooth muscle after photoradiation","volume":"256","author":"Freas","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.rmed.2015.08.005_bib7","first-page":"61","article-title":"Ethanol suppresses L-arginine-induced relaxation response of rat aorta stimulated with bacterial lipopolysaccharide","volume":"35","author":"Hatake","year":"2000","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"10.1016\/j.rmed.2015.08.005_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0002-9343(86)90470-5","article-title":"Cholinergic and neurogenic mechanisms in obstructive airways disease","volume":"81","author":"Bleecker","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.rmed.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.rmed.2015.08.005_bib10","series-title":"Goodman & Gilman's Manual of Pharmacology and Therapeutics","author":"Goodman","year":"2008"},{"key":"10.1016\/j.rmed.2015.08.005_bib11","series-title":"Fitting Models to Biological Data Using Linear and Nonlinear Regression: a Practical Guide to Curve Fitting","author":"Motulsky","year":"2004"},{"key":"10.1016\/j.rmed.2015.08.005_bib12","series-title":"Intuitive Biostatistics","author":"Motulsky","year":"1995"},{"key":"10.1016\/j.rmed.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2015.08.005_bib14","series-title":"Guidelines: Global Strategy for Asthma Management and Prevention","author":"GINA. Global Initiative for Asthma","year":"2011"},{"key":"10.1016\/j.rmed.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.rmed.2015.08.005_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.tiv.2007.03.003","article-title":"A\u00a0mathematical approach to study combined effects of toxicants in\u00a0vitro: evaluation of the Bliss independence criterion and the Loewe additivity model","volume":"21","author":"Goldoni","year":"2007","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.rmed.2015.08.005_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pupt.2013.01.002","article-title":"The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle","volume":"26","author":"Rogliani","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/15412555.2014.922172","article-title":"Translational study searching for synergy between glycopyrronium and indacaterol","volume":"12","author":"Cazzola","year":"2015","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2015.08.005_bib19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.113.204644","article-title":"Effect of the mixed phosphodiesterase 3\/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone","volume":"346","author":"Calzetta","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: curved isoboles","volume":"310","author":"Grabovsky","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2010.04.011","article-title":"The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations","volume":"127","author":"Tallarida","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2015.05.020","article-title":"Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy","volume":"761","author":"Calzetta","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.rmed.2015.08.005_bib25","doi-asserted-by":"crossref","first-page":"26634","DOI":"10.3402\/ecrj.v2.26634","article-title":"Pharmacology of novel treatments for COPD: are fixed dose combination LABA\/LAMA synergistic?","volume":"2","author":"Spina","year":"2015","journal-title":"Eur. Clin. Respir. J."},{"key":"10.1016\/j.rmed.2015.08.005_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pupt.2015.03.007","article-title":"Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3\/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways","volume":"32","author":"Calzetta","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2015.08.005_bib27","first-page":"P291","article-title":"Evaluating lung function response to umeclidinium\/vilanterol (UMEC\/VI) 62.5\/25mcg, UMEC 62.5 mcg and VI 25mcg in COPD patients","volume":"44","author":"Donohue","year":"2014","journal-title":"Eur. Respir. J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115300378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115300378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:33:03Z","timestamp":1760614383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611115300378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0954611115300378"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2015.08.005","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}